| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/06/2004 | WO2003045316A9 Polynucleotide therapy |
| 05/06/2004 | WO2003020219B1 Aerosolized decongestants for the treatment of sinusitis |
| 05/06/2004 | WO2003016351B1 N - cam related compounds modulating cell groth |
| 05/06/2004 | WO2003011903A3 Identification of specific tumor antigens by means of the selection of cdna libraries with sera |
| 05/06/2004 | WO2003010314A3 Gmg-2 polynucleotides and polypeptides and uses thereof |
| 05/06/2004 | WO2002098456A3 Antigens and vectors for vaccination |
| 05/06/2004 | WO2002092788A9 Cytotoxic peptides and peptidomimetics based thereon, and methods for use thereof |
| 05/06/2004 | WO2002091995A8 Method to induce neovascular formation and tissue regeneration |
| 05/06/2004 | WO2002087510A3 Subcellular targeting of therapeutic proteins |
| 05/06/2004 | WO2002085389A9 A non-lethal method for extracting crude hemocyanin from gastropod molluscs |
| 05/06/2004 | WO2002083857A3 68723, sodium/glucose cotransporter family members and uses therefor |
| 05/06/2004 | WO2002083240A9 Aromatase inhibition to enhance assisted reproduction |
| 05/06/2004 | WO2002079387A9 Modular molecular clasps and uses thereof |
| 05/06/2004 | WO2002066502A8 Helicobacter pylori sialic acid binding adhesin, saba and saba - gene |
| 05/06/2004 | WO2002064737A3 Antisense modulation of protein phosphatase 2 catalytic subunit beta expression |
| 05/06/2004 | WO2002055558A8 Novel proteins and nucleic acids encoding same |
| 05/06/2004 | WO2002038108A3 Methods of treating disorders related to apoe |
| 05/06/2004 | WO2002022150A3 Medicament containing activated antithrombin iii |
| 05/06/2004 | WO2002007757A9 Prevention and treatment of sexual arousal disorders |
| 05/06/2004 | US20040088746 Apoptosis-inducing dna sequences |
| 05/06/2004 | US20040087784 Neuronal serine-threonine protein kinase |
| 05/06/2004 | US20040087778 Modified peptides as therapeutic agents |
| 05/06/2004 | US20040087775 Process for production diphtheria toxin |
| 05/06/2004 | US20040087774 Comprises tumor necrosis factor receptor associated factor-(TRAF) inhibitor for diagnosis, prevention and tratment of tumors associated wit h epstein-barr virus |
| 05/06/2004 | US20040087767 FVIIa antagonists |
| 05/06/2004 | US20040087766 Interleukins; fusion proteins; solid phase synthesis; kits |
| 05/06/2004 | US20040087648 Benzothiepine 1, 1-dioxide derivatives, a process for their preparation, pharmaceuticals comprising these compounds, and their use |
| 05/06/2004 | US20040087647 Enzyme inhibitors; prevent thrombosis; anticoagulants |
| 05/06/2004 | US20040087643 Anticoagulants; blood disorders; side effect reduction |
| 05/06/2004 | US20040087631 Anticancer agents; using histone deacetylase; bioavailability |
| 05/06/2004 | US20040087611 Cancer treatment by combination therapy |
| 05/06/2004 | US20040087610 Method and composition for the treatment of cancer |
| 05/06/2004 | US20040087607 Adjust intensity of analgesics; blocking gangliosides |
| 05/06/2004 | US20040087603 (2s) -2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides |
| 05/06/2004 | US20040087579 Antitumor agents, anticancer agents; synergistic mixture; side effect reduction |
| 05/06/2004 | US20040087537 Compositions comprising fusion polypeptides HIV-Nef and NGF, and methods of using the same |
| 05/06/2004 | US20040087536 8-80 nucleobases that specifically hybridize to a nucleic acid molecule encoding a zinc finger protein (kox 1) to inhibit its expression |
| 05/06/2004 | US20040087535 Administering a nitric oxide synthase gene in the form of naked dna; angiogenesis inhibitors |
| 05/06/2004 | US20040087533 Antisense compounds, methods and compositions for treating MMP-12 related inflammatory disorders |
| 05/06/2004 | US20040087528 Delivering plasmid vector encoding HERG (A561V) (human ether-a-go-go related gene) protein to cells afflicted with re-entrant atrial flutter mediated cardiac arrhythmia |
| 05/06/2004 | US20040087525 Polypeptide-human rna binding protein 19 and the polynucleotide encoding it |
| 05/06/2004 | US20040087524 Agent for postoperative use after removal of bone tumours |
| 05/06/2004 | US20040087521 Nucleic acid pharmaceuticals-influenza matrix |
| 05/06/2004 | US20040087515 Compositions methods for improving cardio vascular function |
| 05/06/2004 | US20040087511 Peptide derivatives |
| 05/06/2004 | US20040087509 Method of inducing and maintaining neuronal cells |
| 05/06/2004 | US20040087508 Users for amino acid anticonvulsants |
| 05/06/2004 | US20040087507 Containing amino acid; long term storage stability |
| 05/06/2004 | US20040087506 Methods of modulating FabH activity |
| 05/06/2004 | US20040087505 Agonists for coating medical devices; soluble biologics |
| 05/06/2004 | US20040087504 Novel peptide sy |
| 05/06/2004 | US20040087503 Modified ciliary neurotrophic factor (cntf ) with reduced immunogenicity |
| 05/06/2004 | US20040087502 Use of activated coagulation factor Vll for treating thrombolytic therapy-induced major bleedings |
| 05/06/2004 | US20040087499 Peptides that home to tumor lymphatic vasculature and methods of using same |
| 05/06/2004 | US20040087498 Modified factor VII |
| 05/06/2004 | US20040087496 Use of 3-position cyclosporin derivatives for hair growth |
| 05/06/2004 | US20040087495 Non-aqueous injectable formulation preparation with pH adjusted for extended release of somatotropin |
| 05/06/2004 | US20040087494 Glycopeptide carboxy-saccharide derivatives |
| 05/06/2004 | US20040087493 Bioactive fraction of eurycoma longifolia |
| 05/06/2004 | US20040087492 Involving production of lipid mediators, impairment of glycosaminoglycan functioning; sepsis |
| 05/06/2004 | US20040087489 Compositions and methods for the treatment of mycobacterial infections |
| 05/06/2004 | US20040087488 Hydrophilic biopolymer-drug conjugates, their preparation and use |
| 05/06/2004 | US20040087487 Increasing concentration of dopamine neurotransmitter in central nervous system; using glycine-proline-glutamic acid (GPE); neural injury or disease |
| 05/06/2004 | US20040087486 Inhibiting vascular occlusive events; reducing circulating count below normal levels without serious adverse consequence |
| 05/06/2004 | US20040087485 Educated nkt cells and their uses in the treatment of immune-related disorders |
| 05/06/2004 | US20040087484 Treating sexual dysfunction associated with hypertension; angiotensin receptor blocker with either antihypertensive agent or HMG-CoA reductase inhibitor |
| 05/06/2004 | US20040087481 Modulation of cholesteryl ester transfer protein (CETP) activity |
| 05/06/2004 | US20040087035 Using myeloproliferative leukemic inhibitory agents to treatment and/ or prevention platelet related thrombotic and vaso-occlusive disorder |
| 05/06/2004 | US20040087027 Plasmid sequences for diagnosis and treatment of hyperproliferative/cell proliferative disorders; antitumor agents |
| 05/06/2004 | US20040087016 Using cyclin dependent kinase inhibitors to return differentiated cells to pluripotent state; tissue engineering and organ transplantation |
| 05/06/2004 | US20040086999 Modified amino acid sequences for prevention and treatment of cancer, vision defects and inflammatory diseases |
| 05/06/2004 | US20040086993 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
| 05/06/2004 | US20040086988 Enzyme catalyst; polypeptides; crystal structure |
| 05/06/2004 | US20040086978 Pancreas-derived plasminogen activator inhibitor |
| 05/06/2004 | US20040086977 Fusion polypeptides of human serum albumin and a therapeutically active polypeptide |
| 05/06/2004 | US20040086976 Genetically engineered erythropoietin for diagnosis, prevention and treatment of thrombis, cancer, neovascularization, inflammation and autoimmune diseases |
| 05/06/2004 | US20040086975 Comprises adenoid expressed chemokine for modulating, treating and diagnosing abnormalities in inflamed or diseased tissues |
| 05/06/2004 | US20040086974 Comprises human tumor suppressor protein for treatment and prevention of cell proliferative disorders; antitumor/anticarcinogenic/antiproliferative agents |
| 05/06/2004 | US20040086973 Calmodulin-dependent protein kinase inhibitor for treatment and prevention of nervous system disorders |
| 05/06/2004 | US20040086971 Comprises nucleotide sequences coding extracellular matrix protein for prevention and treatment of inflammatory, immune and thrombotic disorders |
| 05/06/2004 | US20040086966 Comprises g-protein couple receptor polypeptide for diagnosis and treatment of cell proliferative disorders; gene therapy; immunotherapy |
| 05/06/2004 | US20040086964 Culture product of cells; nutrient solutions; genetic engineered proteins |
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086949 Solid phase synthesis; immunology; vaccines; for generating antibodies; kits |
| 05/06/2004 | US20040086945 Hairless protein-interacting partner complexes and methods thereto |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086941 Method for screening mch receptor antagonist/agonist |
| 05/06/2004 | US20040086937 Screening for antagonists and/or inhibitors of bacterial propagation and infection; mimetics |
| 05/06/2004 | US20040086935 Comprises nucleotide sequences coding heterodimeric receptors for identifying modulator of tumor metastasis and inflammation |
| 05/06/2004 | US20040086934 Comprises striamin polypeptide for identifying modulator for treatment and prevention of cardiovascular, tumor and muscle disorders |
| 05/06/2004 | US20040086933 Protein and gene involved in myocyte differentiation |
| 05/06/2004 | US20040086926 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/06/2004 | US20040086923 Comprises polypeptide with carbamoyl phosphate synthase (CPS) activity for identifying modulators which prevent and/or treat cancer and metabolic disorders |
| 05/06/2004 | US20040086921 Comprises nucleotide sequences coding membrane proteins for diagnosis and treatment of metabolic disorders |
| 05/06/2004 | US20040086920 STARS - a muscle-specific actin-binding protein |
| 05/06/2004 | US20040086916 Polypeptide for use in diagnosis and treatment of liver cancers; the polypeptides are overexpressed in tumor and preneoplastic cells in general |
| 05/06/2004 | US20040086913 Human genes and gene expression products XVI |
| 05/06/2004 | US20040086911 Nucleotide sequences for treatment of autoimmune, tumor and viral diseases; gene expression inhibition |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086903 Comprises nucleotide sequences coding promoter and retinoid carrier protein for identifying modulator for treatment of fertility disorders |